![]() |
市場調查報告書
商品編碼
2046683
植物性因型鑒定設備市場-全球產業規模、佔有率、趨勢、機會、預測:按設備、應用、地區和競爭對手分類,2021-2031年Plant Genotyping Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Equipment, By Application, By Region & Competition, 2021-2031F |
||||||
全球植物性因型鑒定設備市場預計將從 2025 年的 8.0541 億美元成長到 2031 年的 12.2095 億美元,複合年成長率為 7.18%。
該市場涵蓋了諸如PCR系統和DNA測序儀等專用設備,這些設備旨在分析植物物種內的遺傳變異。這一成長主要受糧食安全需求增加和氣候適應型作物發展需求的推動,而這些都需要對作物的遺傳特徵有精準的了解。此外,農業領域對縮短育種週期的重視也促進了基因組研究和開發的投資。國際種子聯盟(ISF)發布的《2024年報告》也印證了這種趨勢,報告指出,約91%的專家預期新的育種突破將加速改良品種的培育。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 8.0541億美元 |
| 市場規模:2031年 | 1,220,950,000 美元 |
| 複合年成長率:2026-2031年 | 7.18% |
| 成長最快的細分市場 | SNP基因型鑒定裝置 |
| 最大的市場 | 北美洲 |
另一方面,市場擴張的一大障礙是建立高通量基礎設施所需的大量資本投入。引進設備的高昂成本,加上資料管理費用,對小規模研究機構而言構成了極高的進入門檻。因此,這些資金限制,再加上精通複雜基因組數據分析的人員短缺,可能會限制基因型鑒定技術的普及,尤其是在價格敏感型地區。
對具有氣候變遷耐受性和抗病性的作物新品種的需求日益成長,是全球植物性因型鑒定設備市場的主要驅動力。隨著極端天氣和病蟲害模式的改變威脅著農業生產力,育種者越來越依賴高通量基因型鑒定來識別與耐旱性和抗病性相關的特定等位基因。這種迫切性迫使研究機構升級其基因組基礎設施,以加速品種開發並篩檢龐大的遺傳資源庫。例如,2024年7月,美國農業部(USDA)宣布投資860萬美元用於育種研究,旨在提高作物產量和氣候變遷耐受性,這是其「植物育種促進農業生產」舉措的一部分。這直接導致了對先進PCR系統和測序儀的採購訂單。
同時,私營部門對農業生物技術和種子研發的投資激增,為大規模基因組計畫提供了必要的資金,進一步推動了市場成長。領先的種子企業正積極增加預算,將分子標記和基因組選擇納入其研發流程,從而帶動了對基因型鑒定耗材和設備的需求。 Corteva AgriScience於2024年1月發布的2023年第四季及全年財報顯示,其年度研發支出達到13.37億美元,體現了其對創新的持續投入。這種企業支出對設備製造商而言是利好因素,例如Pacific Biosciences在2024年公佈的數據顯示,其2023年全年銷售額成長56%,達到2.05億美元。這主要得益於植物性因組分析所需的新型定序系統的推出。
高通量基礎設施所需的大量資本投入是全球植物性因分型設備市場擴張的主要障礙。購買諸如新一代DNA定序儀和自動化PCR系統等先進設備需要大量的初期投資,這對中小企業和公共資助的研究機構造成了不成比例的影響。這些資金需求構成了巨大的進入門檻,導致先進的基因組分析能力集中在少數資金雄厚的跨國公司手中,迫使小規模的機構依賴效率較低的傳統育種方法。
這種經濟負擔不僅限於硬體,還包括數據管理和分析相關的高昂營運成本。解讀龐大的基因組資料集極為複雜,需要昂貴的軟體和專業人員,而這些資源在價格敏感地區往往十分匱乏。這種資金差距直接阻礙了開發中國家)的技術應用。國際種子聯盟(ISF)2024年的一項調查發現,全球種子產業約有三分之一的受訪者認為,增加公共和私人投資是推動進一步創新的關鍵因素,這證實了當前的資金限制是市場發展的一大障礙。
將人工智慧 (AI) 應用於即時基因分型數據分析,從根本上改變了育種過程,使基因發現擺脫了生物生長季節的時間限制。先進的機器學習演算法現在被用於處理海量基因組資料集,使育種者無需進行大規模田間試驗即可預測複雜的表現型性狀並確定最佳親本組合。這項技術進步使研究機構能夠繞過傳統的瓶頸,並大幅縮短新品種的上市時間。根據拜耳公司 2024 年 12 月發表的一篇報導《人工智慧如何重塑作物遺傳學》,人工智慧新功能的整合已使育種週期縮短多達 15 倍,並將整體產品開發時間縮短兩年。
向高通量次世代定序(NGS) 平台的轉變,正逐步鞏固其作為工業規模解碼複雜植物性因組的產業標準地位。與傳統的微陣列方法不同,NGS 系統能夠提供高解析度,從而檢測不同遺傳資源中的罕見突變和結構變化,這對於滿足現代商業農業海量資料需求至關重要。全球科學研究生態系中領導企業的持續良好財務表現,也支撐著對先進定序架構的系統性依賴。根據 Illumina 公司於 2025 年 2 月發布的“2024 會計年度第四季及全年報告”,該公司全年營收達 43 億美元,凸顯了儘管經濟波動劇烈,但市場對定序技術的需求依然強勁且持續。
The Global Plant Genotyping Equipment Market is projected to expand from USD 805.41 Million in 2025 to USD 1220.95 Million by 2031, registering a CAGR of 7.18%. This market encompasses specialized instruments such as PCR systems and DNA sequencers designed to analyze genetic variations within plant species. Growth is primarily driven by the escalating need for food security and the development of climate-resilient crops, requiring precise genetic characterization. Additionally, the agricultural sector's focus on shortening breeding cycles fuels investment in genomic research. This reliance is underscored by the International Seed Federation, which reported in 2024 that approximately 91% of sector experts anticipate that new breeding breakthroughs will accelerate the creation of improved crop varieties.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 805.41 Million |
| Market Size 2031 | USD 1220.95 Million |
| CAGR 2026-2031 | 7.18% |
| Fastest Growing Segment | SNP Genotyping Equipment |
| Largest Market | North America |
Conversely, a significant obstacle impeding market expansion is the substantial capital investment required for high-throughput infrastructure. The elevated costs associated with acquiring instrumentation, along with expenses for data management, create formidable entry barriers for smaller research entities. Consequently, these financial constraints, combined with a shortage of personnel skilled in interpreting complex genomic data, may restrict the widespread adoption of genotyping technologies, particularly in price-sensitive regions.
Market Driver
The rising necessity for climate-resilient and disease-resistant crop varieties acts as a primary catalyst for the Global Plant Genotyping Equipment Market. As extreme weather events and shifting pest patterns threaten agricultural productivity, breeders increasingly rely on high-throughput genotyping to identify specific alleles responsible for drought tolerance and pathogen resistance. This urgency compels research institutions to upgrade their genomic infrastructure to accelerate variety development and screen vast germplasm libraries. For instance, the United States Department of Agriculture (USDA) announced in July 2024, under the 'Plant Breeding for Agricultural Production' initiative, an investment of $8.6 million specifically for breeding research to improve crop productivity and climate resilience, directly translating into procurement orders for advanced PCR systems and sequencers.
A simultaneous surge in private sector investments in agri-biotech and seed development further propels market growth by providing the capital necessary for large-scale genomic projects. Major seed companies are aggressively expanding their budgets to integrate molecular markers and genomic selection into their pipelines, thereby driving the consumption of genotyping consumables and instruments. According to Corteva Agriscience's January 2024 report on 'Fourth Quarter and Full-Year 2023 Results,' annual research and development expenses reached $1.337 billion, reflecting a sustained commitment to innovation. This corporate spending benefits equipment providers, as evidenced by Pacific Biosciences, which reported in 2024 that its full-year revenue for 2023 grew by 56% to $200.5 million, largely driven by the adoption of new sequencing systems critical for plant genome analysis.
Market Challenge
The substantial capital investment required for high-throughput infrastructure stands as a primary obstacle restricting the expansion of the Global Plant Genotyping Equipment Market. Procurement of advanced instrumentation, such as next-generation DNA sequencers and automated PCR systems, demands heavy upfront expenditure that disproportionately impacts small-to-medium enterprises and publicly funded research stations. These financial requirements create significant entry barriers, effectively consolidating advanced genomic capabilities within a limited circle of well-funded multinational corporations while forcing smaller entities to rely on less efficient, traditional breeding methods.
This financial burden extends beyond hardware to include the high operational costs associated with data management and analysis. The complexity of interpreting vast genomic datasets requires expensive software and specialized personnel, resources that are often scarce in price-sensitive regions. This funding gap directly impedes technology adoption in developing agricultural economies where modernization is most critical. According to the International Seed Federation in 2024, approximately one-third of global seed sector respondents identified the urgent need for increased private and public investment as the critical factor to unlock further innovation, confirming that current financial limitations act as a severe brake on market progress.
Market Trends
The application of Artificial Intelligence for Real-Time Genotyping Data Interpretation is fundamentally reshaping breeding pipelines by decoupling genetic discovery from the time constraints of biological growing seasons. Advanced machine learning algorithms are now utilized to ingest vast genomic datasets, enabling breeders to predict complex phenotypic traits and identify optimal parent combinations without the need for extensive field trials. This technological evolution allows research entities to bypass traditional bottlenecks, significantly compressing the time required to bring novel varieties to market. According to Bayer's December 2024 article 'A look at how AI is rewriting crop genetics,' the integration of new AI capabilities has enabled the reduction of breeding cycles by up to 15 times and cut overall product development timelines by two years.
The transition to High-Throughput Next-Generation Sequencing (NGS) Platforms is simultaneously solidifying its position as the industry standard for decoding complex plant genomes at an industrial scale. Unlike legacy microarray methods, NGS systems provide the deep resolution necessary to detect rare variants and structural changes across diverse germplasm, a capability that is essential for modern commercial agriculture's high-volume data demands. This systemic reliance on advanced sequencing architecture is evidenced by the sustained financial performance of leading technology providers who underpin the global research ecosystem. According to Illumina's February 2025 'Financial Results for Fourth Quarter and Fiscal Year 2024' report, the company achieved a full-year revenue of $4.3 billion, highlighting the substantial and ongoing market demand for sequencing technologies despite broader economic fluctuations.
Report Scope
In this report, the Global Plant Genotyping Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Plant Genotyping Equipment Market.
Global Plant Genotyping Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: